title: [Initial assessment and follow-up of benign prostatic hyperplasia: systematic review of the literature by the LUTS committee of the French Urological Association].
abstract: OBJECTIVE
  To perform an update on the initial evaluation and follow-up of benign prostatic hyperplasia (BPH).
  
  
  METHODS
  A systematic review of recent literature was performed. Level of evidence of publications was evaluated.
  
  
  CONCLUSIONS
  Objectives of the initial evaluation are to assess the link between low urinary tract symptoms (LUTS) and BPH, to evaluate the bother associated to LUTS, assess a complicated bladder outlet obstruction (BOO), diagnose an adenocarcinoma of the prostate if it modifies the therapeutic strategy, and establish an evolutive profile of the disease. Clinical assessment with digital rectal examination, evaluation of symptoms by a dedicated questionnaire and urine analysis are the first steps of BPH evaluation. Bladder diary is useful to objective storage symptoms. Uroflowmetry and post-void residual volume assessment are useful if BOO is suspected. Measure of serum creatinine and ultrasound exam of the urinary tract are second line explorations. Urine cytology, neurological evaluation, urethrocystoscopy, urodynamics with pressure-flow studies are useful if the link between LUTS and BPH is unclear. PSA dosage is used for prostate cancer screening or as a prognostic marker of BPH evolution.
authors.affiliation: Service de chirurgie urologique, hôpital Dupuytren, CHU de Limoges, 2, avenue Martin-Luther-King, Limoges 87042, France. aureliendescazeaud@gmail.com
authors.forename: A
authors.initials: A
authors.lastname: Descazeaud
authors.forename: G
authors.initials: G
authors.lastname: Robert
authors.forename: N B
authors.initials: NB
authors.lastname: Delongchamps
authors.forename: J-N
authors.initials: JN
authors.lastname: Cornu
authors.forename: C
authors.initials: C
authors.lastname: Saussine
authors.forename: O
authors.initials: O
authors.lastname: Haillot
authors.forename: M
authors.initials: M
authors.lastname: Devonec
authors.forename: M
authors.initials: M
authors.lastname: Fourmarier
authors.forename: C
authors.initials: C
authors.lastname: Ballereau
authors.forename: B
authors.initials: B
authors.lastname: Lukacs
authors.forename: O
authors.initials: O
authors.lastname: Dumonceau
authors.forename: A R
authors.initials: AR
authors.lastname: Azzouzi
authors.forename: A
authors.initials: A
authors.lastname: de la Taille
mesh_terms: D018450:Disease Progression; D006801:Humans; D008297:Male; D010808:Physical Examination; D017410:Practice Guidelines as Topic; D017430:Prostate-Specific Antigen / Q000097:blood; D011470:Prostatic Hyperplasia / Q000175:diagnosis*; D016482:Urinalysis; D014555:Urination Disorders / Q000209:etiology
chemical_list: D017430:Prostate-Specific Antigen